NCT07075718Phase 2Recruiting

Phase 2 Trial to Evaluate the Safety and Efficacy of the Second Generation Travoprost Intracameral Implant

Study sponsor: Glaukos Corporation

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Primary completion2028-03Estimated
Enrollment · participants110Estimated
Source updated2026-09-17Last update listed in the registry record
Version history

Changes to this trial

Last 12 months
Pro unlocks the full available history and CSV export. View Pro features

· 2 fields changed

Planned enrollment decreased by 500 participants

− Before

610 participants (planned)

+ After

110 participants (planned)

Phase changed

− Before

PHASE2, PHASE3

+ After

PHASE2

Check registry source